Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting

Bing Lu; Xiaojia Huang; Jingxin Mo; Wei Zhao
April 2016
Frontiers in Pharmacology;4/12/2016, p1
Academic Journal
No abstract available.


Related Articles

  • Targeting Nanoparticles as Drug Delivery Systems for Cancer Treatment. Subramani, Karthikeyan; Hosseinkhani, Hossein; Khraisat, Ameen; Hosseinkhani, Mohsen; Pathak, Yashwant // Current Nanoscience;May2009, Vol. 5 Issue 2, p135 

    This review article discusses about the current cancer treatment techniques and the extensive recent research studies done on nanoparticles as carrier systems for the delivery of anticancer drug molecules in cancer treatment. A variety of nanoparticles of different structural and chemical...

  • Cancer nanotechnology. Jagdale, Swati C.; Shah, Tejas P.; Kuchekar, Bhanudas S.; Chabukswar, Aniruddha R.; Baviskar, Dhiraj T. // Asian Journal of Pharmaceutics (Medknow Publications & Media Pvt;2009, Vol. 3 Issue 1, p4 

    Cancer nanotechnology is the latest trend in cancer therapy. It helps the pharmacist to formulate the product with maximum therapeutic value and minimum or negligible range side effects. Cancer is the disease in which the abnormal cells are quite similar to the normal cell with just minute...

  • IMD-0354 Targets Breast Cancer Stem Cells: A Novel Approach for an Adjuvant to Chemotherapy to Prevent Multidrug Resistance in a Murine Model. Gomez-Cabrero, Azucena; Wrasidlo, Wolfgang; Reisfeld, Ralph A. // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Although early detection of breast cancer improved in recent years, prognosis of patients with late stage breast cancer remains poor, mostly due to development of multidrug resistance (MDR) followed by tumor recurrence. Cancer stem cells (CSCs), with higher drug efflux capability and other stem...

  • Nanoparticle-Mediated Delivery of Therapeutic Drugs. Ponnappan, Nisha; Chugh, Archana // Pharmaceutical Medicine - New Zealand;Jun2015, Vol. 29 Issue 3, p155 

    Nanotechnology-based pharmaceutics is a fast emerging field in the diagnosis and therapy of a number of human diseases, including cancer. Nanoparticles offer a stable means to achieve targeted drug delivery to various cells and tissues. They have been investigated for drug delivery to different...

  • Nanoparticles in Drug Delivery and Cancer Therapy: The Giant Rats Tail. Prabhu, Vinod; Uzzaman, Siddik; Grace, Viswanathan Mariammal Berlin; Guruvayoorappan, Chandrasekharan // Journal of Cancer Therapy;Aug2011, Vol. 2 Issue 3, p325 

    Nanotechnology has the potential to offer solutions to these current obstacles in cancer therapies, because of its unique size and large surface-to-volume ratios. Nanoparticles may have properties of self-assembly, stability, specificity, drug encapsulation and biocompatibility as a result of...

  • Drug Targeting Systems for Cancer Therapy: Nanotechnological Approach. Aydin, R. Seda Tigli // Mini Reviews in Medicinal Chemistry;Nov2014, Vol. 14 Issue 13, p1048 

    Progress in cancer treatment remains challenging because of the great nature of tumor cells to be drug resistant. However, advances in the field of nanotechnology have enabled the delivery of drugs for cancer treatment by passively and actively targeting to tumor cells with nanoparticles....

  • Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Huile Gao; Zhi Yang; Shuang Zhang; Shijie Cao; Shun Shen; Zhiqing Pang; Xinguo Jiang // Scientific Reports;8/30/2013, p1 

    Nanoparticles (NPs) were widely used in drugs/probes delivery for improved disease diagnosis and/or treatment. Targeted delivery to cancer cells is a highly attractive application of NPs. However, few studies have been performed on the targeting mechanisms of these ligand-modified delivery...

  • In vitro and In vivo anticancer activity of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles. Venkatasubbu, G.; Ramasamy, S.; Reddy, G.; Kumar, J. // Biomedical Microdevices;Aug2013, Vol. 15 Issue 4, p711 

    Targeted drug delivery using nanocrystalline materials delivers the drug at the deseased site. This increases the efficacy of the drug in killing the cancer cells. Surface modifications were done to target the drug to a particular receptor on the cell surface. This paper reports synthesis of...

  • Cancer Targeted Nanoparticles Specifically Induce Apoptosis in Cancer Cells and Spare Normal Cells. Kanwar, Jagat R.; Kanwar, Rupinder K.; Mahidhara, Ganesh; Chun Hei Antonio Cheung // Australian Journal of Chemistry;Jan2012, Vol. 65 Issue 1, p5 

    Curing cancer is the greatest challenge for modern medicine and finding ways to minimize the adverse effects caused by chemotherapeutic agents is of importance in improving patient's physical conditions. Traditionally, chemotherapy can induce various adverse effects, and these effects are mostly...

  • Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Golebiewska, Anna; Bougnaud, Sébastien; Stieber, Daniel; Brons, Nicolaas H. C.; Vallar, Laurent; Hertel, Frank; Klink, Barbara; Schröck, Evelin; Bjerkvig, Rolf; Niclou, Simone P. // Brain: A Journal of Neurology;May2013, Vol. 136 Issue 5, p1462 

    The identification and significance of cancer stem-like cells in malignant gliomas remains controversial. It has been proposed that cancer stem-like cells display increased drug resistance, through the expression of ATP-binding cassette transporters that detoxify cells by effluxing exogenous...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics